Cargando…
Cardiovascular risk factors, micro and macrovascular complications at diagnosis in patients with young onset type 2 diabetes in India: CINDI 2
CONTEXT: Type 2 diabetes mellitus (T2DM) in young adults is increasing in India. Data on the prevalence of cardiovascular (CV) risk factors and complications associated with young-onset T2DM (YOD) at the time of diagnosis of diabetes are limited. This data can aid in aggressive diabetes management,...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4743371/ https://www.ncbi.nlm.nih.gov/pubmed/26904479 http://dx.doi.org/10.4103/2230-8210.172277 |
_version_ | 1782414353709924352 |
---|---|
author | Sosale, Bhavana Sosale, Aravind R. Mohan, Anjana R. Kumar, Prassanna M. Saboo, Banshi Kandula, Sai |
author_facet | Sosale, Bhavana Sosale, Aravind R. Mohan, Anjana R. Kumar, Prassanna M. Saboo, Banshi Kandula, Sai |
author_sort | Sosale, Bhavana |
collection | PubMed |
description | CONTEXT: Type 2 diabetes mellitus (T2DM) in young adults is increasing in India. Data on the prevalence of cardiovascular (CV) risk factors and complications associated with young-onset T2DM (YOD) at the time of diagnosis of diabetes are limited. This data can aid in aggressive diabetes management, CV risk reduction, and prevention of complications. AIM: To determine the prevalence of CV risk factors, micro and macrovascular complications in patients with newly diagnosed YOD. To assess the percentage of patients who require statin therapy based on current American Diabetes Association (ADA) guidelines. SETTINGS AND DESIGN: This was a retrospective cross-sectional study of 1500 patients with newly detected YOD across seven centers from 2013 to 2015. DESIGNS AND METHODS: Patients were evaluated for complications of diabetes and CV risk factors such as body mass index (BMI), hypertension, dyslipidemia, and smoking. STATISTICAL ANALYSIS: Measurements have been presented as mean ± standard deviation; results on categorical measurements have been presented in percentages. RESULTS: The mean age, glycated hemoglobin and BMI were 34.7 ± 4.2 years, 9.9 ± 2.4%, and 26.8 ± 4.7 kg/m(2). Hypertension, dyslipidemia, BMI >23 kg/m(2), and smoking were presented in 27.6%, 62.4%, 84.2%, and 24%. Diabetic retinopathy, neuropathy, and nephropathy were seen in 5.1%, 13.2%, and 0.9%. Ischemic heart disease, peripheral vascular disease, and stroke were presented in 0.7%, 2%, and 0.1%. As per current guidelines, 95.33% needed statin therapy. CONCLUSION: This study demonstrates that patients with YOD have micro and macrovascular complications at diagnosis. Nearly, every patient required a statin to reduce CV risk. This highlights the importance of screening patients with YOD for CV risk factors and complications of diabetes at the time of diagnosis. |
format | Online Article Text |
id | pubmed-4743371 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-47433712016-02-22 Cardiovascular risk factors, micro and macrovascular complications at diagnosis in patients with young onset type 2 diabetes in India: CINDI 2 Sosale, Bhavana Sosale, Aravind R. Mohan, Anjana R. Kumar, Prassanna M. Saboo, Banshi Kandula, Sai Indian J Endocrinol Metab Original Article CONTEXT: Type 2 diabetes mellitus (T2DM) in young adults is increasing in India. Data on the prevalence of cardiovascular (CV) risk factors and complications associated with young-onset T2DM (YOD) at the time of diagnosis of diabetes are limited. This data can aid in aggressive diabetes management, CV risk reduction, and prevention of complications. AIM: To determine the prevalence of CV risk factors, micro and macrovascular complications in patients with newly diagnosed YOD. To assess the percentage of patients who require statin therapy based on current American Diabetes Association (ADA) guidelines. SETTINGS AND DESIGN: This was a retrospective cross-sectional study of 1500 patients with newly detected YOD across seven centers from 2013 to 2015. DESIGNS AND METHODS: Patients were evaluated for complications of diabetes and CV risk factors such as body mass index (BMI), hypertension, dyslipidemia, and smoking. STATISTICAL ANALYSIS: Measurements have been presented as mean ± standard deviation; results on categorical measurements have been presented in percentages. RESULTS: The mean age, glycated hemoglobin and BMI were 34.7 ± 4.2 years, 9.9 ± 2.4%, and 26.8 ± 4.7 kg/m(2). Hypertension, dyslipidemia, BMI >23 kg/m(2), and smoking were presented in 27.6%, 62.4%, 84.2%, and 24%. Diabetic retinopathy, neuropathy, and nephropathy were seen in 5.1%, 13.2%, and 0.9%. Ischemic heart disease, peripheral vascular disease, and stroke were presented in 0.7%, 2%, and 0.1%. As per current guidelines, 95.33% needed statin therapy. CONCLUSION: This study demonstrates that patients with YOD have micro and macrovascular complications at diagnosis. Nearly, every patient required a statin to reduce CV risk. This highlights the importance of screening patients with YOD for CV risk factors and complications of diabetes at the time of diagnosis. Medknow Publications & Media Pvt Ltd 2016 /pmc/articles/PMC4743371/ /pubmed/26904479 http://dx.doi.org/10.4103/2230-8210.172277 Text en Copyright: © Indian Journal of Endocrinology and Metabolism http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Sosale, Bhavana Sosale, Aravind R. Mohan, Anjana R. Kumar, Prassanna M. Saboo, Banshi Kandula, Sai Cardiovascular risk factors, micro and macrovascular complications at diagnosis in patients with young onset type 2 diabetes in India: CINDI 2 |
title | Cardiovascular risk factors, micro and macrovascular complications at diagnosis in patients with young onset type 2 diabetes in India: CINDI 2 |
title_full | Cardiovascular risk factors, micro and macrovascular complications at diagnosis in patients with young onset type 2 diabetes in India: CINDI 2 |
title_fullStr | Cardiovascular risk factors, micro and macrovascular complications at diagnosis in patients with young onset type 2 diabetes in India: CINDI 2 |
title_full_unstemmed | Cardiovascular risk factors, micro and macrovascular complications at diagnosis in patients with young onset type 2 diabetes in India: CINDI 2 |
title_short | Cardiovascular risk factors, micro and macrovascular complications at diagnosis in patients with young onset type 2 diabetes in India: CINDI 2 |
title_sort | cardiovascular risk factors, micro and macrovascular complications at diagnosis in patients with young onset type 2 diabetes in india: cindi 2 |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4743371/ https://www.ncbi.nlm.nih.gov/pubmed/26904479 http://dx.doi.org/10.4103/2230-8210.172277 |
work_keys_str_mv | AT sosalebhavana cardiovascularriskfactorsmicroandmacrovascularcomplicationsatdiagnosisinpatientswithyoungonsettype2diabetesinindiacindi2 AT sosalearavindr cardiovascularriskfactorsmicroandmacrovascularcomplicationsatdiagnosisinpatientswithyoungonsettype2diabetesinindiacindi2 AT mohananjanar cardiovascularriskfactorsmicroandmacrovascularcomplicationsatdiagnosisinpatientswithyoungonsettype2diabetesinindiacindi2 AT kumarprassannam cardiovascularriskfactorsmicroandmacrovascularcomplicationsatdiagnosisinpatientswithyoungonsettype2diabetesinindiacindi2 AT saboobanshi cardiovascularriskfactorsmicroandmacrovascularcomplicationsatdiagnosisinpatientswithyoungonsettype2diabetesinindiacindi2 AT kandulasai cardiovascularriskfactorsmicroandmacrovascularcomplicationsatdiagnosisinpatientswithyoungonsettype2diabetesinindiacindi2 |